Mitrionics' Accelerated Computing Platform selected by QUT for accelerating algorithms

NewsGuard 100/100 Score

Mitrionics AB, the technology leader in FPGA-based hybrid computing, today announced that the Queensland University of Technology (QUT) High Performance Computing group has selected the Mitrion™ Accelerated Computing Platform to explore several projects designed to accelerate algorithms in different application areas. Initial acceleration projects will focus on molecular dynamics, UAV on-board processing, genetic computations, elementary mathematical functions, and computational fluid dynamics. To leverage the full potential of their existing FPGA-equipped computing system, QUT purchased the Mitrion Virtual Processor and Mitrion Software Development Kit (with Mitrion-C parallel programming language) as a rapid development tool to accelerate their algorithms.

"The Mitrion SDK is an important addition to our suite of high performance software development tools, making the potential benefits of reconfigurable computing and co-processing more accessible to our researchers at a lower programming effort," said Dr Neil Kelson, Research User Services Manager, High Performance Computing & Research Support Group, Queensland University of Technology. "Compared with traditional HDLs, our preliminary experience suggests that Mitrion-C will allow our users to more rapidly explore FPGA-based acceleration in a diverse range of areas, from vision and path planning in UAVs and robots, molecular dynamics analysis of nanoscale materials, to Computational Fluid Dynamics simulations."

"Queensland University of Technology is recognized worldwide for its quality education and excellence in applied research for diverse industries," noted Robert Wall, director of business development for Mitrionics AB. "Mitrionics is excited to collaborate with QUT on their projects to accelerate applications for the benefit of their different departments and scientific users."

SOURCE: Mitrionics

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Diet's role in fighting vitiligo highlighted in new research